PfizerAIDS

Glaxo and Pfizer signal new approach to HIV drug research and development

GlaxoSmithKline (GSK) and Pfizer are spinning out all HIV/AIDS-related R&D and marketed drugs into a separate, jointly-controlled company.

22 Apr 2009

News

Subscribe to PfizerAIDS

Get the free Science|Business newsletter

Receive our news bulletin each Tuesday & Thursday and news about bridging Europe’s east-west innovation gap twice a month in The Widening.

Sign up for the Bulletin

Sign up for The Widening

Jobs

Eureka is seeking a Process Expert Evaluation and Ethics

CSIC is looking for a R&I Internationalisation Technician

Climate news

Read our expanding news coverage of climate technologies and policies here.

News
- The Widening
- R&D Policy
- Health
- Energy
- Climate
- Digital
- Defence
Reports
Events
The Network
Communications Services
About Us
- Contact
- Team
- Privacy
- Careers